Anna Norhammar Selected Research

Anna Norhammar Research Topics

Disease

45	Myocardial Infarction 01/2024 - 06/2002
30	Type 2 Diabetes Mellitus (MODY) 05/2024 - 05/2006
21	Heart Failure 11/2021 - 06/2015
12	Cardiovascular Diseases (Cardiovascular Disease) 12/2023 - 01/2017
12	Stroke (Strokes) 11/2021 - 01/2008
11	Glucose Intolerance 01/2024 - 10/2003
9	Diabetes Mellitus 01/2022 - 06/2002
6	Insulin Resistance 12/2023 - 12/2015
5	Acute Coronary Syndrome 11/2023 - 07/2014
4	Prediabetic State (Prediabetes) 10/2023 - 11/2008
4	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 11/2008
4	Atrial Fibrillation 11/2021 - 01/2017
3	Thrombosis (Thrombus) 05/2024 - 06/2015
3	Periodontitis 01/2024 - 01/2015
3	Neoplasms (Cancer) 10/2023 - 01/2017
3	Infarction (Infarctions) 09/2021 - 01/2019
2	Heart Diseases (Heart Disease) 12/2023 - 11/2021
2	Unstable Angina 11/2023 - 11/2022
2	Periodontal Diseases (Periodontal Disease) 01/2022 - 01/2015
2	Inflammation (Inflammations) 01/2022 - 01/2015
2	Hypoglycemia (Reactive Hypoglycemia) 01/2017 - 07/2016
1	Tooth Loss 05/2024
1	Necrosis 01/2024
1	Periapical Periodontitis (Apical Periodontitis) 01/2024
1	Overweight 12/2023
1	Abdominal Obesity 12/2023
1	Obesity 12/2023
1	Body Weight (Weight, Body) 11/2022
1	Infections 01/2022
1	Renal Insufficiency (Renal Failure) 11/2021
1	Chronic Renal Insufficiency 01/2021
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 03/2020
1	Hemorrhage 11/2019

Drug/Important Bio-Agent (IBA)

51	Glucose (Dextrose)FDA LinkGeneric 01/2024 - 06/2002
13	SodiumIBA 11/2022 - 01/2017
10	Insulin (Novolin)FDA Link 11/2023 - 09/2007
6	Metformin (Glucophage)FDA LinkGeneric 10/2023 - 01/2008
6	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2021 - 01/2017
4	omega-Chloroacetophenone (Mace)IBA 12/2023 - 01/2018
4	empagliflozinIBA 11/2023 - 01/2017
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2015
4	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2020 - 07/2014
4	dapagliflozinIBA 12/2019 - 01/2017
3	Indicators and Reagents (Reagents)IBA 05/2024 - 01/2019
3	Blood Glucose (Blood Sugar)IBA 10/2023 - 06/2002
3	Insulin-Like PeptidesIBA 01/2019 - 12/2015
3	Insulin-Like Growth Factor Binding Protein 1IBA 01/2018 - 09/2007
3	Sitagliptin Phosphate (Januvia)FDA Link 01/2016 - 07/2014
2	Mannose (D-Mannose)IBA 12/2023 - 01/2022
2	C-PeptideIBA 11/2023 - 01/2022
2	LipidsIBA 01/2022 - 08/2014
2	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2021 - 10/2018
2	Antiphospholipid AntibodiesIBA 03/2020 - 01/2019
2	Sodium-Glucose Transport ProteinsIBA 01/2018 - 07/2017
2	Insulin-Like Growth Factor Binding ProteinsIBA 12/2015 - 09/2007
1	ImmunosorbentsIBA 01/2024
1	Interleukin-6 (Interleukin 6)IBA 01/2024
1	Interleukin-2 (IL2)IBA 01/2024
1	Triglycerides (Triacylglycerol)IBA 01/2024
1	C-Reactive ProteinIBA 01/2024
1	HDL CholesterolIBA 01/2024
1	Interleukin-8 (Interleukin 8)IBA 01/2024
1	EnzymesIBA 01/2024
1	LDL CholesterolIBA 12/2023
1	oxidized low density lipoproteinIBA 12/2023
1	SymportersIBA 11/2022
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2022
1	peptidoglycan recognition proteinIBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	ORALIT (ORS)IBA 12/2021
1	Testosterone (Sustanon)FDA Link 09/2021
1	Androgen Receptors (Androgen Receptor)IBA 09/2021
1	IncretinsIBA 01/2021
1	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2021
1	Immunoglobulin G (IgG)IBA 03/2020
1	CreatinineIBA 01/2019
1	Cystatin CIBA 07/2017
1	AdiponectinIBA 01/2017
1	LeptinIBA 01/2017
1	CanagliflozinIBA 01/2017
1	AdipokinesIBA 01/2017
1	Arginine Vasopressin (Argipressin)IBA 01/2016
1	Hydrocortisone (Cortisol)FDA LinkGeneric 12/2015
1	Peroxidase (Myeloperoxidase)IBA 01/2015
1	Metalloproteases (Metalloproteinases)IBA 01/2015
1	Matrix Metalloproteinase 8 (Neutrophil Collagenase)IBA 01/2015
1	Tissue Inhibitor of Metalloproteinase-1IBA 01/2015
1	Insulin-Like Growth Factor I (IGF-1)IBA 09/2007

Therapy/Procedure

9	Therapeutics 12/2023 - 01/2018
5	Percutaneous Coronary Intervention 01/2021 - 05/2006
4	Stents 05/2024 - 06/2015
2	Glycemic Control 05/2024 - 12/2015
1	Cardiac Rehabilitation 12/2023
1	Dental Scaling 12/2021
1	Drug-Eluting Stents 01/2021
1	Secondary Prevention 01/2021
1	Ambulatory Care (Outpatient Care) 12/2018
1	Critical Care (Surgical Intensive Care) 12/2007
1	Length of Stay 05/2003